These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16948380)

  • 41. What's your assessment? Impetigo.
    Bielan B
    Dermatol Nurs; 1999 Oct; 11(5):354-5. PubMed ID: 10670342
    [No Abstract]   [Full Text] [Related]  

  • 42. Dupilumab in the Treatment of Dyshidrosis: A Report of Two Cases.
    Weston GK; Hooper J; Strober BE
    J Drugs Dermatol; 2018 Mar; 17(3):355-356. PubMed ID: 29537454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The nursing management of a patient receiving Prograf as a primary immunosuppressive agent.
    Hasselder AS
    EDTNA ERCA J; 1998; 24(2):14-5, 18. PubMed ID: 10392057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What's your assessment? Erythema multiforme.
    Bielan B
    Dermatol Nurs; 2003 Feb; 15(1):41-2. PubMed ID: 12656002
    [No Abstract]   [Full Text] [Related]  

  • 45. [Dyshidrotic pemphigoid].
    Beylot-Barry M; Doutre MS; Beylot C
    Ann Dermatol Venereol; 1995; 122(3):81-3. PubMed ID: 7486727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What's your assessment? Epidermoid inclusion cyst.
    Bielan B
    Dermatol Nurs; 1999 Jun; 11(3):195, 208. PubMed ID: 10670334
    [No Abstract]   [Full Text] [Related]  

  • 47. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    van der Laan JR
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1816; author reply 1817. PubMed ID: 16121669
    [No Abstract]   [Full Text] [Related]  

  • 48. Lack of response of alopecia areata to pimecrolimus cream.
    Rigopoulos D; Gregoriou S; Korfitis C; Gintzou C; Vergou T; Katrinaki A; Kalogeromitros D
    Clin Exp Dermatol; 2007 Jul; 32(4):456-7. PubMed ID: 17537231
    [No Abstract]   [Full Text] [Related]  

  • 49. Pompholyx.
    Summers A
    Emerg Nurse; 2007 Sep; 15(5):18-9. PubMed ID: 17902549
    [No Abstract]   [Full Text] [Related]  

  • 50. Topical treatment for atopic dermatitis in the 21st century.
    Johnson SM; Kincannon JM; Dudney DL;
    J Ark Med Soc; 2004 Sep; 101(3):86-90. PubMed ID: 15384500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What's your assessment? Eosinophilic cellulitis (Wells' syndrome).
    Melton JH
    Dermatol Nurs; 2007 Jun; 19(3):258, 265. PubMed ID: 17626504
    [No Abstract]   [Full Text] [Related]  

  • 52. Two therapeutic challenges: facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream.
    Bilaç DB; Ermertcan AT; Sahin MT; Oztürkcan S
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):72-3. PubMed ID: 18355205
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the physical effectiveness of antimycotics on human skin].
    Tronnier H
    Arch Klin Exp Dermatol; 1966; 227(1):617-21. PubMed ID: 4228533
    [No Abstract]   [Full Text] [Related]  

  • 54. What's your assessment? Bowen's disease.
    Bielan B
    Dermatol Nurs; 1999 Aug; 11(4):273-4. PubMed ID: 10670357
    [No Abstract]   [Full Text] [Related]  

  • 55. What's your assessment? Varicella.
    Petros HM
    Dermatol Nurs; 2008 Feb; 20(1):47-9, 53. PubMed ID: 18380295
    [No Abstract]   [Full Text] [Related]  

  • 56. Pompholyx (dyshidrosis). A case study.
    Wilson M; Maglietta T
    J Am Podiatr Med Assoc; 1985 Mar; 75(3):155-8. PubMed ID: 3156983
    [No Abstract]   [Full Text] [Related]  

  • 57. [How much does neurodermatitis affect quality of life?].
    Abeck D
    Krankenpfl J; 2005; 43(4-6):119. PubMed ID: 16171065
    [No Abstract]   [Full Text] [Related]  

  • 58. Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase.
    Konstantopoulou M; Belgi A; Griffiths KD; Seale JR; Macfarlane AW
    BMJ; 2005 Feb; 330(7487):350-1. PubMed ID: 15705694
    [No Abstract]   [Full Text] [Related]  

  • 59. Topical pimecrolimus: a novel therapeutic option for Netherton syndrome.
    Oji V; Beljan G; Beier K; Traupe H; Luger TA
    Br J Dermatol; 2005 Nov; 153(5):1067-8. PubMed ID: 16225628
    [No Abstract]   [Full Text] [Related]  

  • 60. [What are these summertime skin manifestations?].
    Rowe E
    MMW Fortschr Med; 2015 May; 157(10):32. PubMed ID: 26019085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.